## Synovial Histopathology in Rheumatoid Arthritis ### Cellular Composition of the RA Synovium The synovial membrane in established rheumatoid arthritis shows a characteristic inflammatory infiltrate: **Key Point:** The hallmark histological finding is a chronic inflammatory infiltrate dominated by CD4+ T lymphocytes (helper T cells), B lymphocytes, plasma cells, and activated macrophages, often organized into lymphoid aggregates or germinal center-like structures. ### Detailed Cellular Architecture | Cell Type | Location | Function | |-----------|----------|----------| | CD4+ T cells | Throughout synovium, germinal centers | Orchestrate immune response, produce cytokines (TNF-α, IL-6, IL-17) | | B lymphocytes & plasma cells | Germinal centers, perivascular | Produce RF and anti-CCP antibodies | | Macrophages | Lining layer, perivascular | Antigen presentation, cytokine production | | Fibroblasts | Synovial lining | Produce MMPs, perpetuate inflammation | | Neutrophils | Synovial fluid (not tissue) | Abundant in joint fluid, not in synovial tissue | ### Why This Pattern Matters **High-Yield:** The presence of organized lymphoid aggregates with germinal center-like structures indicates ongoing local B-cell activation and antibody production within the joint — this is pathognomonic for RA and distinguishes it from other arthritides. **Clinical Pearl:** The synovial infiltrate is predominantly T-cell driven in early RA, but as disease progresses, B-cell and plasma cell infiltration increases, correlating with higher RF and anti-CCP titers and more severe erosive disease. ### Pathogenic Sequence 1. CD4+ T cells recognize autoantigens (citrullinated proteins) presented by HLA-DR molecules 2. Activated T cells produce pro-inflammatory cytokines (TNF-α, IL-6, IL-17, IL-2) 3. B cells are activated and differentiate into plasma cells 4. Plasma cells produce RF (IgM, IgG) and anti-CCP antibodies 5. Immune complexes form and activate complement 6. Macrophages and fibroblasts produce MMPs → cartilage and bone erosion **Key Point:** This T-cell and B-cell dependent process is why TNF-α inhibitors and B-cell depleting agents (rituximab) are effective in RA. [cite:Robbins 10e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.